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8 ABSTRACT: The scandium triﬂate-catalyzed cycloaddition reaction
9 of polycyclic 1,2-dithiolethiones to maleimides is described. The
10 reaction constitutes an easy approach to linear as well as branched
11 oligomeric cis-fused dihydro[1,3]dithiolo[4,5-c]pyrrole-4,6-dione
12 rings interconnected by 3,5-diylidenethiomorpholine-2,6-dithione or
13 ylidene-6-thioxo[1,2]dithiolo[3,4-b][1,4]thiazin-3-one groups. The
14 presence of highly colored, highly polarized push−pull α,β-
15 unsaturated thione groups in their structures make these compounds
16 sensitive to the presence of mercury(II) cation in organic or mixed
17 organic/aqueous solvents.
18 ■ INTRODUCTION
19 Polyheterocyclic compounds bearing 1,3-dithiole1 and 1,3-
20 dithiolane2 moieties are important donor units in new
21 electronic materials and molecular devices such as extended
22 tetrathiafulvalene derivatives,3 organic superconductors,4 push−
23 pull chromophores,5 switchable organic materials,6 receptors,7
24 shape-persistent macrocycles, and conducting polymer wires.8
25 Despite the enormous synthetic eﬀorts in the search for these
26 new materials, the number of methods currently used for this
27 chemistry is surprisingly low, being conserved unchanged for a
28 long time.9 Less common synthetic methods for the
29 preparation of 1,3-dithiole derivatives include 1,3-dipolar
30 cycloadditions of 1,2-dithiole-3-thiones and activated triple
31 bonds, which permit multiple cycloadditions in one pot,
32 thereby giving rise to extended TTF derivatives by very short
33 reaction pathways.10 Despite the rich chemistry shown by these
34 reactions, related alternatives are scarce. Thus, the photo-
35 chemical reactions of 1,2-dithiole-3-thiones and nonactivated
36 alkenes are known to give unstable adducts that can be trapped
37 by dienophiles such as N-phenylmaleimide.11 Notwithstanding
38 the extensive chemistry developed in the ﬁeld of 1,2-dithiole-3-
39 thiones,12 their cycloaddition reactions with classical activated
40 double bonds such as maleimides are not known. The only
41 loosely related known reaction is a single example of a thermal
42 cycloaddition of 2,4-diphenylisothiazoline-5-thione and N-
43 phenylmaleimide that was reported long time ago by
44 McKinnon and co-workers.13 Apparently, the thermal reaction
45 of N-substituted maleimides and 1,2-dithiole-3-thiones does not
46 work under heating in high-boiling-point solvents. Such a
47 reaction, if it should be possible, would constitute a very good
48approach to dihydro derivatives of the 2-methylene-4H-
49[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione system, an almost
50unknown system14 that could be potentially useful in the search
51for new materials and pharmacological leads. Therefore, in this
52paper we describe the scandium triﬂate-catalyzed cycloaddition
53of polycyclic dithiolethiones to maleimides as an unprece-
54dented approach to branched oligomeric polyheterocyclic 1,3-
55dithiolanes.
56■ RESULTS AND DISCUSSION
57We selected a suitable catalyst, scandium triﬂate, which was
58very eﬀective for the 1,3-cycloaddition reactions of polyheter-
59ocyclic dithiolethiones and activated alkynes,15 to study the
60cycloaddition reaction of the most reactive dithiolethiones we
61had in hand and commercial or easily synthesized maleimides.
62Our starting materials, 4-alkylbis[1,2]dithiolo[3,4-b:4′,3′-e]-
63[1,4]thiazin-3-oxo-5-thiones and -3,5-dithiones can be prepared
64in one-pot reactions from Hünig’s base or N,N-(diisopropyl)-
65benzylamine in a selective fashion and therefore are fast entries
66to complex heterocyclic chemistry.10a We ﬁrst selected to use 4-
67ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3-oxo-5-thione16
68(1) in catalyzed reactions with commercial maleimides 2a−j. In
69this way, 1 and 2a−j reacted equimolecularly in reﬂuxing
70dichloromethane for 1 h in the presence of scandium triﬂate
71(25% mol) to give, after workup and column chromatography,
72the corresponding orange solid adducts, 5-substituted 2-(4-
73ethyl-3-oxo-6-thioxo[1,2]dithiolo[3,4-b][1,4]thiazin-5-ylidene)-
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74 dihydro[1,3]dithiolo[4,5-c]pyrrole-4,6-diones 3a−j, in yields of
s1 75 up to 88% (Scheme 1).
76 All of the obtained compounds showed a single spot on the
77 TLC silica plates, but their 1H NMR spectra clearly showed two
78 sets of signals, each composed of two doublets at δ 4.5−6.0,
79 corresponding the C3a and C6a protons (the pair of cis-
80 bridgehead protons in the dithiolopyrrole system) for every
81 compound, in a roughly equimolecular amount, and two
82 complex multiplets for the signals of the methylene protons of
83 the ethyl group. Therefore, the complex 1H NMR spectra are
84 due to the slow inversion of the pyramidal nitrogen in the 1,4-
85 thiazine ring and consequently to the presence of nitrogen
86 inversion conformers. Two chiral centers at the C3a and C6a
87 positions are generated by the 1,3-dipolar cycloaddition
88 reaction with the maleimide, causing the α-methylene hydrogen
89 atoms of the N-substituent of the starting substrate 1 to
90 become diastereotopic in the cycloadduct and thus to show
91 magnetic nonequivalence in the 1H NMR spectra. Therefore,
92 the two protons of the dithiolopyrrole system (H3a and H6a)
93 are structurally nonequivalent. Indeed both the endo- and exo-
94 1,3-dipolar cycloaddition reactions lead to enantiomeric
s2 95 dithiolopyrrole rings (Scheme 2). In a characteristic example,
96 compound 3f showed a set of two partially superposed sextets
97 centered at δ 3.24 (ddq, J = 25.9, 14.2, 6.9 Hz) for one
98 methylene proton and another set of two partially superposed
99 sextets centered at δ 3.56 (ddq, J = 24.7, 14.6, 7.3 Hz) for the
100 other methylene proton along with four doublets, two at δ 5.28
101 and 5.02 (J = 8.5 Hz) for the pair of dithiolopyrrole protons of
102 one conformer and two at δ 5.18 and 4.81 (J = 9.0 Hz) for the
103 pair of dithiolopyrrole protons of the other conformer.
104 The transformation among the conformational isomers SYN
105 and ANTI was studied by DFT calculations performed on a
106 simpliﬁed model of compounds 3a−j. The SYN/ANTI
107transformation can be explained as an inversion of the
108conﬁguration of the amine nitrogen atom. In order to avoid
109complications arising from the simultaneous inversion on the
110nitrogen atom and the rotation of the C−C bond in the ethyl
111group, this ethyl group was simpliﬁed to a methyl group. In
112these theoretical calculations, we found that for this simpliﬁed
113model of 3a−j the SYN and ANTI conformers have similar
114stabilities, with a free energy diﬀerence of 0.319 kcal·mol−1.
115This small diﬀerence is in good agreement with the
116experimental observation of both conformers in solution, and
117on the basis of the calculated free energy diﬀerence between the
118conformers, the statistical distribution of the population at 298
119K is 63.2% for the ANTI conformer and 36.8% for the SYN
120 f1conformer (Figure 1). The estimated barrier for the SYN/
121ANTI transformation in the simpliﬁed model is 17.6 kcal/mol,
122which is high enough to allow the observation of both isomers
123in the 1H NMR experiments at room temperature.17 Similar
124calculations performed on a nonsimpliﬁed structure of
125compound 3a aﬀorded populations of 62.7% for ANTI-3a
126and 37.3% for SYN-3a (61/39 experimental), in good
127 f2agreement with the experimental results (Figure 2).
128All of these compounds decomposed at the melting point in
129a cycloreversion reaction followed by thermal desulfuration,
130giving rise to 4-ethylbis[1,2]dithiolo[4,3-b:3′,4′-d]pyrrole-3-
131oxo-5-thione (4), a known product of thermal desulfuration
132 s3of 116b (Scheme 3). As a characteristic example, upon slow
133melting of 3c in a heating chamber under a microscope, yellow
134crystals of 4 were formed by sublimation as 3c melted.
135Compound 4 was characterized by mass spectrometry and
136compared to a synthetic sample.
137In the same way, 4-benzylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]-
138thiazin-3-oxo-5-thione18 (5) and commercial maleimides 2a−
139c,e−g reacted equimolecularly in reﬂuxing dichloromethane for
1402−4 h in the presence of scandium triﬂate (25% mol) to give,
Scheme 1. Reaction of Bisdithioloketothione 1 and
Maleimides 2a−j
aIsolated yields.
Scheme 2. Mechanism of the Reaction between
Bisdithioloketothione 1 and Maleimides and Nitrogen
Inversion of the 1,4-Thiazine Ring
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141 after workup and column chromatography, the corresponding
142 orange solid adducts, 5-substituted 2-(4-benzyl-3-oxo-6-thioxo-
143 [1,2]dithiolo[3,4-b][1,4]thiazin-5-ylidene)dihydro[1,3]-
144 dithiolo[4,5-c]pyrrole-4,6-diones 6a−c,e−g, in yields of up to
s4 145 74% (Scheme 4). In this case, the inversion of the pyramidal
146 nitrogen in the 1,4-thiazine ring was evidenced in the 1H NMR
147 spectra by the presence of two pairs of doublets, one for each of
148 the benzyl methylene protons, and two sets of signals, each
149 composed of two doublets at δ 4.5−6.0, corresponding to the
150 pair of cis-dithiolopyrrole protons for every compound, in
151 amounts from equimolecular to 2:1. In a characteristic example,
152 the 1H NMR spectrum of 6f showed two pairs of doublets at δ
153 4.40/4.12 (J = 14.1 Hz) and δ 4.37/4.19 (J = 14.1 Hz) in a 2:1
154 proportion for the two benzyl methylene protons and two pairs
155 of doublets at δ 5.83/5.58 (J = 8.9 Hz) and δ 5.66/5.35 (J = 9.2
156 Hz) in a 2:1 proportion for the two pairs of dithiolopyrrole
157 protons.
158 On the other hand, 4-ethylbis[1,2]dithiolo[3,4-b:4′,3′-e]-
159 [1,4]thiazin-3,5-dithione16 (7) and 2 equiv of commercial
160 maleimides 2b,f,g reacted in reﬂuxing dichloromethane for 1−2
161 h in the presence of scandium triﬂate (25% mol with respect to
162 2b,f,g) to give, after workup and column chromatography, the
163corresponding orange solid adducts, 5,5′-disubstituted 2,2′-(4-
164ethyl-2,6-dithioxothiomorpholine-3,5-diylidene)bis(5-methyl-
165{or aryl}dihydro-4H-[1,3]dithiolo[4,5-c]pyrrole-4,6-dione)s
166 s58b,f,g, in yields of up to 67% (Scheme 5). In this case, several
167conformers are expected, therefore complicating the otherwise
168simple 1H NMR spectrum of every compound. In this way, the
169
1H NMR spectrum of 8b showed four sets of signals (eight
170doublets) for the dithiolopyrrole protons (δ 5.0−6.0) in
171diﬀerent proportions, whereas 8f showed only two main
172equimolecular conformers and traces of two others and 8g
173showed only one main conformer and traces of two others in
174the same region of the 1H NMR spectrum, probably for steric
175reasons.
176Moreover, bisdithioloketothione16 1 reacted with commercial
177bismaleimides 9a and 9b and the synthesized bismaleimide 9c19
178in reﬂuxing dichloromethane for 1 h in the presence of
Figure 1. DFT-calculated structures of the SYN and ANTI conformers
and of the transition state (TS) for the SYN/ANTI transformation of a
model compound.
Figure 2. DFT-calculated structures of the ANTI and SYN conformers
of 3a.
Scheme 3. Thermal Decomposition of 3c
Scheme 4. Reaction of Bisdithioloketothione 5 and
Maleimides 2a−c,e−g
aIsolated yields.
Scheme 5. Reaction of Bisdithiolodithione 7 and Maleimides
2b,f,g
aIsolated yields.
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179 scandium triﬂate (25% mol) to give, after workup and column
180 chromatography, the corresponding orange solid monoadducts
181 10a and 10b or the diadducts 11a−c in yields of up to 55%
s6f3 182 (Scheme 6). The structures of compounds 10a−b and 11a−c
f3 183 are represented in Figure 3. The expected compound 10c was
184 not isolated, probably because of a lack of stability; therefore, in
185 this case only compound 11c was obtained. The presence of
186 two dithiolopyrrole heterocycles in 11a−c was evidenced in the
187
1H NMR spectra by again the presence of four sets of signals
188 (eight doublets) for the heterocyclic protons (δ 4.5−5.5). In
189 contrast, the presence of only one dithiolopyrrole system in 10a
190 and 10b was evidenced in their 1H NMR spectra by the
191 presence of only two sets of signals (four doublets) for the
192 heterocyclic protons (δ 4.5−5.5).
193 In the case of monoadducts 10, the presence of a maleimide
194 nucleus makes the products suitable for a second cycloaddition
195 reaction. Therefore, bisdithiolodithione16 7 and 2 equiv of
196 maleimide 10a reacted in reﬂuxing dichloromethane for 6 h in
197 the presence of scandium triﬂate (25% mol) to give, after
198 workup and column chromatography, the corresponding
s7 199 orange solid adduct 12 in 74% yield (Scheme 7). Some traces
200 of the corresponding monoadduct were also recovered from the
201 column, but the compound was not suﬃciently stable for a
202 correct characterization. Compound 12 possesses a remarkable
203 stable structure in which all of the spectroscopic characteristics
204found in the 1H NMR spectra of compounds 3f−h and 8f−g
205are preserved, showing a complex mixture of conformers.
206Furthermore, 1, 2, or 3 equiv of bisdithioloketothione16 1
207and trismaleimide 1320 reacted in reﬂuxing dichloromethane for
2084 h in the presence of scandium triﬂate (25% mol with respect
209to 1) to give, after workup and column chromatography, the
210corresponding orange solid monoadduct 14, diadduct 15, or
211 s8triadduct 16, respectively, in yields of up to 41% (Scheme 8).
212Variable amounts of the starting materials and adduct were
213recovered in each case, and the yields given in Scheme 8 are
214only for the main product obtained in each reaction. In this
215case, the yields were lower because of the lack of selectivity, but
216the compounds were reasonably stable and could be
217characterized by spectroscopy and microanalysis as in the
218previous cases.
219All of these compounds were obtained within a small window
220between the reactivity of the starting materials and the stability
221of the products; this series of reactions was possible because of
222the presence of scandium triﬂate as the catalyst of the hitherto
223unknown 1,3-cycloaddition reaction between dithiolethiones
224and maleimides. The catalysis permitted the reaction to be
Scheme 6. Reaction of Bisdithioloketothione 1 and
Bismaleimides 9a−c
aIsolated yields. Figure 3. Structures of 10a−b and 11a−c.
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225 performed at a suitable temperature to allow the formation and
226 recovery of the obtained products in almost all cases. These
227 new compounds are thermally sensitive, undergoing a cyclo-
228 reversion reaction followed by thermal desulfuration at the
229 melting point. All of these compounds hold in their structure at
230 least one α,β-unsaturated thione group, which is a well-known
231 heterodiene system that is frequently used for hetero-Diels−
232 Alder cycloaddition reactions with activated alkynes.15 In the
233 present case, all of the attempted reactions under uncatalyzed
234 or catalyzed conditions gave the product of sequential 1,3-
235 dipolar cycloreversion (presumably to give the starting material
236 1) followed by the 1,3-dipolar cycloaddition of dithiolethione 1
237 and the new dipolarophile. In a characteristic example,
238 compound 3f was subjected to reaction with dibenzoylacety-
239 lene (17) under diverse conditions15b but only the known
240 compound 1815b was obtained with no traces of the expected
s9 241 compound 19 (Scheme 9).
242 On the other hand, the highly polarized push−pull α,β-
243 unsaturated thione group is responsible for the color exhibited
244 by these compounds. Compounds 3a−j display an orange color
245 in solution that may undergo changes in the presence of the
246 most common cations or anions. All of them behaved similarly
247 when tested with the same cations or anions, independently of
248 the N-alkyl or N-aryl group, and therefore, the behavior of two
249 of the most representative examples, 3f and 8f, is reported.
250 Addition of 1 equiv or more of Hg2+ to 10−4 M solutions of 3f
251 (λmax = 394 nm, ε = 10 946 M
−1 cm−1) in MeCN resulted in a
252 dramatic change of color from yellow to maroon. This response
253 was selective for Hg2+, and addition of several equivalents of
254 other cations (Ag+, Ni2+, Sn2+, Cd2+, Zn2+, Pb2+, Cu2+, Fe3+,
255 Sc3+, and Al3+) as their perchlorate or triﬂate salts resulted in no
f4 256 appreciable changes (Figure 4).
257 A quantitative UV−vis titration of a 10−4 M solution of 3f in
258 MeCN with Hg2+ (added as the perchlorate salt in MeCN)
259 showed that as Hg2+ was added (up to 2 equiv), the original
260 absorption maximum bands centered at 394 and 345 nm
261 decreased and some new bands appeared at 550, 430, and 310
f5 262 nm, generating isosbestic points at 290, 333, and 402 nm
263 f5(Figure 5a). After the addition of more than 2 equiv of Hg2+,
264the new bands slowly decreased with the disappearance of the
265isosbestic point at 402 nm. The titration proﬁle ﬁtted nicely to
266a 1:1 binding model (Figure 5b),21 and the association constant
267was calculated as log K = 4.94 ± 0.09. The Job’s plot analysis of
268the UV−vis titration carried out in MeCN revealed a maximum
269at a mole fraction of 50% (Figure 5c), in accordance with the
270proposed 1:1 binding stoichiometry. The Hg2+ detection limit
271of a 10−4 M solution of 3f in MeCN, calculated in UV−vis
Scheme 7. Synthesis and Structure of 12 Scheme 8. Reaction of Bisdithioloketothione 1 and
Trismaleimide 13
aIsolated yields.
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272 absorption by the blank variability method,22 was 3.69 × 10−6
273 M.
274 The selective sensing action of a 10−4 M solution of 8f in
275 MeCN and 1 equiv or more of Hg2+ in MeCN or water was
276 also very eﬀective, in contrast to the lack of eﬀect of adding 1
277 equiv or more of other cations (Ag+, Ni2+, Sn2+, Cd2+, Zn2+,
278 Pb2+, Cu2+, Fe3+, Sc3+, and Al3+) in MeCN. In this case, a
279 striking color change from yellow to maroon only in the
f6 280 presence of Hg2+ was observed (Figure 6).
281 A quantitative UV−vis titration of a 10−4 M solution of 8f in
282 MeCN with Hg2+ (added as the perchlorate salt in MeCN)
283 showed that addition of Hg2+ resulted in the decrease of the
284 original absorption maximum bands centered at 390 and 417
285 nm and the appearance of a large absorption band from 300 to
286 600 nm (responsible for the observed color) with no
f7 287 appearance of isosbestic points (Figure 7a). Related titrations
288 performed in acetonitrile/water mixtures showed a similar
289 tendency, but a clear isosbestic point at 365 nm was observed
290 (Figure 7b), thus conﬁrming the appearance of a unique
291 equilibrium complex. The titration proﬁle ﬁtted nicely to a 2:1
292 binding model (Figure 7c),21 and the association constants
293 were calculated as log K1 = 3.42 ± 0.14 and log K2 = 4.56 ±
294 0.17. The Job’s plot analysis of the UV−vis titration carried out
295 in MeCN revealed a maximum between mole fractions of 0.60
296 and 0.70 (Figure 7d), in accordance with the proposed 2:1
297 binding stoichiometry. The Hg2+ detection limit of a 10−4 M
298 solution of 8f in MeCN, calculated in UV−vis absorption by
299 the blank variability method,22 was 3.16 × 10−7 M, so 8f
300 showed better performance than 3f.
301 In agreement with previous related chromogenic probes for
302 mercury(II) cation, we assumed that in both cases complex-
303 ation was probably eﬀected through the thione group, leading
304 to the formation of complexes in which Hg2+ extends the
305 conjugation between the 1,3-dithiolane and thione groups,
306 causing in both cases bathochromic shifts of the main UV−vis
307absorption band in UV−visible. As a representative example,
308the structure of the complex 3f[Hg2+]·MeCN was obtained by
309 f8DFT calculations (Figure 8). The model found with ligand 3f
310and a mercury(II) cation showed a preference for coordination
311of the mercury cation to the thione sulfur and a preferred
312orientation through the sulfur atom of the thiomorpholine
313moiety.
Scheme 9. 1,3-Dipolar Cycloreversion/Cycloaddition of 3f
Figure 4. Color changes of 10−4 M samples of 3f in MeCN in the
presence of 1 equiv of various cations.
Figure 5. (a) UV−vis titration curves, (b) titration proﬁle (λmax = 312
nm), and (c) Job’s plot (λmax = 393 nm) for a 10
−4 M solution of 3f in
MeCN titrated with Hg2+.
Figure 6. Color changes of 10−4 M samples of 8f in MeCN in the
presence of 2 equiv of various cations.
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314 Comparison of the HOMOs and LUMOs of 3f and
315 3f[Hg2+]·MeCN showed that the HOMO of 3f is a
316 nonbonding orbital spread through the 5-(1,3-dithiolan-2-
317 ylidene)[1,2]dithiolo[3,4-b][1,4]thiazin-3-oxo-6-thione moiety
318 and the LUMO is an antibonding orbital spread through the 2-
319 (1,3-dithiolan-2-ylidene)dithiocarboxylate moiety. In contrast,
320the HOMO of 3f[Hg2+]·MeCN is a nonbonding orbital on the
321N-phenylpyrrolidine-2,5-dione moiety and the LUMO of
3223f[Hg2+]·MeCN is an σ antibonding orbital spread through
323the 2-(1,3-dithiolan-2-ylidene)dithiocarboxylate−Hg2+ moiety
324 f9(Figure 9), thus proving that the extension of the conjugation
325between the 1,3-dithiolane group and the complexed thione
326group is responsible for the bathochromic shift in the UV
327titration.
328■ CONCLUSION
329We have described the scandium triﬂate-catalyzed cycloaddition
330of polycyclic dithiolethiones to maleimides. The reaction
331constitutes an unprecedented approach to linear as well as
332branched oligomeric cis-fused [1,3]dithiolo[4,5-c]pyrrole rings
333interconnected by 3,5-diylidenethiomorpholine-2,6-dithione or
334ylidene-6-thioxo[1,2]dithiolo[3,4-b][1,4]thiazin-3-one groups.
335Both the 1,4-thiazine core and the cis-fused [1,3]dithiolo[4,5-
336c]pyrrole ring are nonplanar nonaromatic rings that display the
337presence of inversion conformers of the 1,4-thiazine nitrogen.
338The presence of highly colored, highly polarized push−pull α,β-
339unsaturated thione groups in their structures make these
340compounds sensitive to the presence of mercury(II) cation in
341organic or mixed organic/aqueous solvents with remarkable
342selectivity, as shown for two simple derivatives. Therefore, the
343more structurally complex compounds are good candidates in
344mercury removal schemes, as absorbants for mercury(II) salts,
345and as selective indicators. This is due to the enormous number
346of sulfur heteroatoms (in either acceptor or donor positions)
347that these new molecular systems display, such as the 1,3-
348dithiolanes and the conjugated thione groups.
349■ EXPERIMENTAL SECTION
350General. The reactions were conducted under dry nitrogen. The
351solvents were previously distilled under nitrogen over phosphorus
352pentoxide, calcium hydride, or sodium ﬁlaments. Melting points were
353not corrected. Infrared spectra were registered in potassium bromide
354tablets. NMR spectra were recorded in DMSO-d6, CDCl3, CD3CN, or
355CD3OD. Chemical shifts are reported in parts per million with respect
356to residual solvent protons,23 and coupling constants (JX−X′) are
357reported in hertz. DEPT experiments from selected samples permitted
358the assignment of 13C NMR chemical shifts. Elemental analyses of C,
359H, and N were performed for all new products. High-resolution mass
360spectra were taken in a quadrupole mass spectrometer by electron
361impact, FAB, or LSIMS. 4-Ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]-
362thiazin-3-oxo-5-thione16 (1), 4-benzylbis[1,2]dithiolo[3,4-b:4′,3′-e]-
363[1,4]thiazin-3-oxo-5-thione18 (5), 4-ethylbis[1,2]dithiolo[3,4-b:4′,3′-
364e][1,4]thiazin-3,5-dithione16 (7), bismaleimide 9c,19 and trismaleimide
Figure 7. (a, b) Hg2+ UV−vis titration curves of (a) 10−4 M 8f in
MeCN and (b) 5 × 10−4 M 8f in MeCN/water. (c) Titration proﬁle
(λmax = 390 nm). (d) Job’s plot (λmax = 295 nm).
Figure 8. DFT-calculated structure of the complex 3f[Hg2+]·MeCN.
Figure 9. HOMOs and LUMOs of 3f and the 3f[Hg2+]·MeCN
complex.
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365 1320 were prepared following the reported methodologies. Analytical
366 TLC was performed on silica gel 60 plates. Flash column
367 chromatography was carried out on silica gel (0.040−0.063 mm).
368 General Procedure for the Catalytic Cycloaddition of 4-
369 Ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3-oxo-5-thione
370 (1) and Maleimides 2a−j. Maleimide 2a−j (1 equiv) and Sc(OTf)3
371 (19 mg, 0.038 mmol) were added under nitrogen to 1 (50 mg, 0.15
372 mmol) dissolved in dry dichloromethane (10 mL), and the mixture
373 was reﬂuxed for 1 h. Then the solvent was evaporated under reduced
374 pressure, and the residue was puriﬁed by column chromatography
375 (silica 230−400 mesh, eluting with light petroleum/dichloromethane
376 60/40 to dichoromethane/ethyl acetate mixtures) to get 3a−j.
377 Analytical samples were obtained by thin-layer chromatography
378 (glass plates, silica 20 cm × 20 cm × 0.1 cm, eluting with
379 dichloromethane/ethyl acetate mixtures).
380 (3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
381 dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)dihydro-4H-[1,3]-
382 dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3a). 44 mg (68%), orange
383 solid, mp 119−120 °C (dec.) (DCM/EtOAc 1:1), 61/39 ratio of
384 conformers. IR (KBr): ν̃ = 3460, 2853, 1721, 1712, 1631, 1283 cm−1.
385
1H NMR (CD3COCD3, 300 MHz): δ 10.86 (br s, 0.39H, NH
386 conformer B), 10.73 (br s, 0.61H, NH conformer A), 5.63 (d, J = 8.6
387 Hz, 0.61H, CH conformer A), 5.46 (d, J = 9.0 Hz, 0.39H, CH
388 conformer B), 5.32 (d, J = 8.6 Hz, 0.61H, CH conformer A), 5.12 (d, J
389 = 9.0 Hz, 0.39H, CH conformer B), 3.59−3.48 (m, 1H, CH2 conformer
390 A/B), 3.34−3.19 (m, 1H, CH2 conformer A/B), 1.14 (t, J = 7.2 Hz,
391 1.83H, CH3 conformer A), 1.13 (t, J = 7.2 Hz, 1.17H, CH3 conformer
392 B). 13C NMR (CDCl3, 75 MHz): δ 201.2, 201.1, 184.9, 184.8, 172.8,
393 172.5, 172.2, 172.1, 171.1, 165.1, 163.2, 150.9, 150.7, 133.6, 133.1,
394 132.7 (Cq conformer A/B), 60.8 (CH conformer A), 59.9 (CH
395 conformer B), 52.6 (CH conformer A), 51.3 (CH conformer B), 48.8
396 (CH2 conformer A), 48.7 (CH2 conformer B), 13.3 (CH3 conformer
397 A), 13.2 (CH3 conformer B). MS (FAB
+): m/z (%) 421 (M+ + 1, 28),
398 391 (18), 323 (34). HRMS (LSIMS): m/z 419.8860; calcd for
399 C12H8N2O3S6
+, 419.8859. Anal. Calcd for C12H8N2O3S6: C 34.27, H
400 1.92, N 6.66. Found: C 34.15, H 2.01, N 6.51.
401 (3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
402 dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-5-methyldihydro-4H-
403 [1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3b). 52 mg (77%),
404 orange solid, mp 88−89 °C (dec.) (DCM/EtOAc 98:2), 57/43 ratio
405 of conformers. IR (KBr): ν̃ = 2923, 1783, 1704, 1677, 1639, 1614
406 cm−1. 1H NMR (CDCl3, 400 MHz): δ 5.13 (d, J = 8.4 Hz, 0.57H, CH
407 conformer A), 5.05 (d, J = 9.2 Hz, 0.43H, CH conformer B), 4.88 (d, J =
408 8.4 Hz, 0.57H, CH conformer A), 4.63 (d, J = 9.2 Hz, 0.43H, CH
409 conformer B), 3.63−3.48 (m, 1H, CH2 conformer A/B), 3.29−3.14 (m,
410 1H, CH2 conformer A/B), 3.11 (s, 1.29H, CH 3 conformer B), 3.05 (s,
411 1.71H, CH3 conformer A), 1.13 (t, J = 7.2 Hz, 3H, CH3 conformer A/
412 B). 13C NMR and DEPT (CDCl3, 100 MHz): δ 201.1, 200.7, 184.7,
413 184.5, 172.9, 172.6, 172.2, 172.1, 171.1, 165.2, 163.0, 151.1, 150.2,
414 133.4, 133.3, 132.5 (Cq conformer A/B), 59.7 (CH conformer A),
415 58.6 (CH conformer B), 51.3 (CH conformer A), 50.1 (CH conformer
416 B), 48.7 (CH2 conformer A), 48.6 (CH2 conformer B), 26.1 (CH3
417 conformer B), 26.0 (CH3 conformer A), 13.3 (CH3 conformer A), 13.2
418 (CH3 conformer B). MS (FAB
+): m/z (%) 434 (M+, 9), 391 (11), 323
419 (11). HRMS (LSIMS): m/z 433.9016; calcd for C13H10N2O3S6
+,
420 433.9016. Anal. Calcd for C13H10N2O3S6: C 35.92, H 2.32, N 6.45.
421 Found: C 35.98, H 2.36, N 6.39.
422 (3aR,6aS)(Z/E)-5-(tert-Butyl)-2-(4-ethyl-3-oxo-6-thioxo-
423 3H,4H-[1,2]dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)dihydro-
424 4H-[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3c). 60 mg (81%),
425 orange solid, mp 94−95 °C (dec.) (DCM), 52/48 ratio of conformers.
426 IR (KBr): ν̃ = 2922, 1704, 1667, 1658, 1642, 1632, 1310, 1190 cm−1.
427
1H NMR (CDCl3, 400 MHz): δ 4.98 (d, J = 8.8 Hz, 0.52H, CH
428 conformer A), 4.85 (d, J = 9.0 Hz, 0.48H, CH conformer B), 4.73 (d, J =
429 8.8 Hz, 0.52H, CH conformer A), 4.44 (d, J = 9.0 Hz, 0.48H, CH
430 conformer B), 3.63−3.52 (m, 1H, CH2 conformer A/B), 3.30−3.19 (m,
431 1H, CH2 conformer A/B), 1.62 (s, 4.68H, CH3 conformer A), 1.58 (s,
432 4.32H, CH3 conformer B), 1.15 (t, J = 7.2 Hz, 1.44H, CH3 conformer B),
433 1.14 (t, J = 7.2 Hz, 1.56H, CH3 conformer A).
13C NMR (CDCl3, 100
434 MHz): δ 200.7, 200.6, 184.7, 184.5, 173.5, 173.3, 172.8, 172.7, 165.6,
435164.1, 151.0, 150.3, 133.4, 133.1, 132.5, 130.9, 60.4 (Cq conformer A/
436B), 60.2 (CH conformer A), 58.7 (CH conformer B), 51.8 (CH
437conformer A), 50.4 (CH conformer B), 48.7 (CH2 conformer A), 48.6
438(CH2 conformer B) 29.7 (3 × CH3 conformer B), 28.1 (3 × CH3
439conformer A), 13.3 (CH3 conformer A), 13.2 (CH3 conformer B). MS
440(FAB+): m/z (%) 477 (M+ + 1, 6), 391 (15), 323 (11). HRMS
441(LSIMS): m/z 475.9485; calcd for C16H16N2O3S6
+, 475.9482. Anal.




446dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3d). 65 mg (88%), orange
447solid, mp 92−93 °C (dec.) (DCM), 52/48 ratio of conformers. IR
448(KBr): ν̃ = 2955, 2927, 1782, 1705, 1666, 1639 cm−1. 1H NMR
449(CDCl3, 400 MHz): δ 5.11 (d, J = 8.6 Hz, 0.52H, CH conformer A),
4505.03 (d, J = 8.9 Hz, 0.48H, CH conformer B), 4.86 (d, J = 8.6 Hz, 0.52H,
451CH conformer A), 4.62 (d, J = 8.9 Hz, 0.48H, CH conformer B), 3.62−
4523.48 (m, 3H), 3.28−3.15 (m, 1H, CH2 conformer A/B), 1.67−1.52
453(m, 2H), 1.37−1.24 (m, 2H), 1.13 (t, J = 7.1 Hz, 1.44H, CH 3
454conformer B), 1.12 (t, J = 7.1 Hz, 1.56H, CH3 conformer A), 0.93 (t, J =
4557.3 Hz, 1.44H, CH3 conformer B), 0.90 (t, J = 7.4 Hz, 1.56H, CH3
456conformer A). 13C NMR and DEPT (CDCl3, 100 MHz): δ 200.9,
457200.5, 184.7, 184.5, 172.8, 172.5, 172.2, 172.0, 165.3, 163.2, 151.1,
458150.3, 133.3, 132.5 (Cq conformer A/B), 59.8 (CH conformer A),
45958.6 (CH conformer B), 51.31 (CH conformer A), 50.1 (CH conformer
460B), 48.7 (CH2 conformer A), 48.6 (CH2 conformer B), 39.9, 29.4, 19.9
461(CH2 conformer A/B), 13.5 (CH3 conformer B), 13.4 (CH3 conformer
462A), 13.3 (CH3 conformer A), 13.2 (CH3 conformer B). MS (FAB
+): m/
463z (%) 477 (M+ + 1, 4), 338 (10). HRMS (LSIMS): m/z 475.9502;
464calcd for C16H16N2O3S6
+, 475.9485. Anal. Calcd for C16H16N2O3S6: C
46540.31, H 3.38, N 5.88. Found: C 40.32, H 3.51, N 5.92.
466(3aR,6aS)(Z/E)-5-Benzyl-2-(4-ethyl-3-oxo-6-thioxo-3H,4H-
467[1,2]dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)dihydro-4H-[1,3]-
468dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3e). 41 mg (52%), orange
469solid, mp 105−106 °C (dec.) (DCM), 52/48 ratio of conformers. IR
470(KBr): ν̃ = 2961, 2924, 1783, 1710, 1666, 1640 cm−1. 1H NMR
471(CDCl3, 400 MHz): δ 7.39−7.27 (m, 5H, HAr), 5.07 (d, J = 8.8 Hz,
4720.52H, CH conformer A), 4.98 (d, J = 9.0 Hz, 0.48H, CH conformer B),
4734.82 (d, J = 8.8 Hz, 0.52H, CH conformer A), 4.73 (s, 0.96H, CH2
474conformer B), 4.66 (s, 1.04H, CH2 conformer A), 4.55 (d, J = 9.0 Hz,
4750.48H, CH conformer B), 3.62−3.47 (m, 1H, CH2 conformer A/B),
4763.26−3.14 (m, 1H, CH2 conformer A/B), 1.13 (t, J = 7.0 Hz, 1.56H,
477CH3 conformer A), 1.12 (t, J = 7.00 Hz, 1.44H, CH3 conformer B).
13C
478NMR (CDCl3, 100 MHz): δ 201.1, 200.6, 184.7, 184.5, 172.5, 172.1,
479171.8, 171.7, 163.0, 151.0, 150.2, 134.4, 133.4, 132.5 (Cq conformer
480A/B), 129.0, 128.9, 128.8, 128.8, 128.4 (CHAr), 59.8 (CH conformer
481A), 58.7 (CH conformer B), 51.3 (CH conformer A), 50.1 (CH
482conformer B), 48.7 (CH2 conformer A), 48.6 (CH2 conformer B), 43.8
483(CH2 conformer A/B), 13.3 (CH3 conformer A), 13.2 (CH3 conformer
484B). MS (FAB+): m/z (%) 511 (M+ + 1, 8), 494 (6), 323 (100). HRMS
485(LSIMS): m/z 509.9323; calcd for C19H14N2O3S6
+, 509.9329. Anal.




490[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3f). 49 mg (64%),
491orange solid, mp 119−120 °C (dec.) (DCM/EtOAc 50:50), 53/47
492ratio of conformers. IR (KBr): ν̃ = 2960, 2923, 1783, 1704, 1677,
4931666, 1639, 1614, 1536 cm−1. 1H NMR (CDCl3, 400 MHz): δ 7.52−
4947.29 (m, 5H, HAr), 5.28 (d, J = 8.6 Hz, 0.53H, CH conformer A), 5.18
495(d, J = 9.0 Hz, 0.47H, CH conformer B), 5.03 (d, J = 8.6 Hz, 0.53H, CH
496conformer A), 4.81 (d, J = 9.0 Hz, 0.47H, CH conformer B), 3.64−3.49
497(m, 1H, CH2 conformer A/B), 3.32−3.17 (m, 1H, CH2 conformer A/
498B), 1.14 (t, J = 6.9 Hz, 3H, conformer A/B). 13C NMR (CDCl3, 100
499MHz): δ 201.1, 200.6, 184.8, 184.5, 171.9, 171.7, 171.1, 164.9, 162.9
500151.2, 150.2, 133.5, 132.4, 130.7 (Cq conformer A/B), 129.3, 129.2,
501126.1, 126.0 (CHAr), 59.9 (CH conformer A), 58.7(CH conformer B),
50251.5 (CH conformer A), 50.0 (CH conformer B), 48.7 (CH2 conformer
503A), 48.6 (CH2 conformer B), 13.3 (CH3 conformer A), 13.2 (CH3
504conformer B). MS (FAB+): m/z (%) 496 (M+ + 1, 9), 338 (27). HRMS
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505 (LSIMS): m/z 496.9239; calcd for [C18H12N2O3S6 + H]
+, 496.9245.
506 Anal. Calcd for C18H12N2O3S6: C 43.53, H 2.44, N 5.64. Found: C
507 43.40, H 2.56, N 5.72.
508 (3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
509 dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-5-(4-iodophenyl)-
510 dihydro-4H-[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3g). 69
511 mg (72%), orange solid, mp 144−145 °C (dec.) (DCM), 55/45
512 ratio of conformers. IR (KBr): ν̃ = 3289, 2922, 1716, 1644, 1285, 1163
513 cm−1. 1H NMR (CDCl3, 400 MHz): δ 7.85−7.79 (m, 2H, HAr), 7.15−
514 7.09 (m, 2H, HAr), 5.25 (d, J = 8.4 Hz, 0.55H, CH conformer A), 5.14
515 (d, J = 9.0 Hz, 0.45H, CH conformer B), 5.00 (d, J = 8.4 Hz, 0.55H, CH
516 conformer A), 4.73 (d, J = 9.0 Hz, 0.45H, CH conformer B), 3.67−3.53
517 (m, 1H, CH2 conformer A/B), 3.33−3.18 (m, 1H, CH2 conformer A/
518 B), 1.16 (t, J = 7.0 Hz, 3H, CH3 conformer A/B).
13C NMR (CDCl3,
519 100 MHz): δ 201.3, 201.1, 184.7, 184.5, 171.4, 171.2, 170.6, 170.6,
520 164.2, 162.3, 151.0, 150.2 (Cq conformer A/B), 138.6, 138.5 (CHAr),
521 132.5, 132.4, 130.6, (Cq), 127.68 (CHAr), 94.9, 94.8 (Cq conformer
522 A/B), 59.9 (CH conformer A), 58.6 (CH conformer B), 51.5 (CH
523 conformer A), 50.4 (CH conformer B), 48.9 (CH2 conformer A), 48.7
524 (CH2 conformer B), 13.3 (CH3 conformer A/B). MS (FAB
+): m/z
525 (%) 623 (M+ + 1, 10), 410 (10), 340 (52). HRMS (LSIMS): m/z
526 622.8204; calcd for [C18H11IN2O3S6 + H]
+, 622.8212. Anal. Calcd for




531 4H-[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (3h). 49 mg (59%),
532 orange solid, mp 139−140 °C (dec.) (DCM/EtOAc 90:10), 55/45
533 ratio of conformers. IR (KBr): ν̃ = 2922, 1790, 1721, 1682, 1602,
534 1558, 1538, 1378, 1263, 1180 cm−1. 1H NMR (CDCl3, 300 MHz): δ
535 8.08−8.01 (m, 2H, HAr), 7.53−7.44 (m, 2H, HAr), 5.32 (d, J = 8.6 Hz,
536 0.55H, CH conformer A), 5.21 (d, J = 9.0 Hz, 0.45H, CH conformer B),
537 5.07 (d, J = 8.6 Hz, 0.55H, CH conformer A), 4.85 (d, J = 9.0 Hz,
538 0.45H, CH conformer B), 3.65−3.48 (m, 1H, CH2 conformer A/B),
539 3.33−3.16 (m, 1H, CH2 conformer A/B), 2.61 (s, 1.35H, CH 3
540 conformer B), 2.60 (s, 1.65H, CH3 conformer A), 1.14 (t, J = 7.2 Hz,
541 1.35H, CH3 conformer B), 1.13 (t, J = 7.1 Hz, 1.65H, CH3 conformer
542 A/B). 13C NMR (CDCl3, 75 MHz): δ 201.2, 200.9, 196.8, 184.8,
543 171.5, 171.3, 170.7, 170.6, 168.9, 164.3, 162.4, 151.1, 150.2, 137.1,
544 137.0, 134.8, 134.7, 134.4, 133.6, 132.4 (Cq conformer A/B), 129.2,
545 129.1, 126.0, 125.3 (CHAr), 60.0 (CH conformer A), 58.6 (CH
546 conformer B), 51.5 (CH conformer A), 50.4 (CH conformer B), 48.8
547 (CH2 conformer A), 48.7 (CH2 conformer B), 26.7 (CH3 conformer
548 A), 26.6 (CH3 conformer B), 13.3 (CH3 conformer A), 13.2 (CH3
549 conformer B). MS (FAB+): m/z (%) 539 (M+ + 1, 10), 215 (100).
550 HRMS (LSIMS): m/z 537.9283; calcd for C20H14N2O4S6
+, 537.9278.
551 Anal. Calcd for C20H14N2O4S6: C 44.59, H 2.62, N 5.20. Found: C
552 44.67, H 2.55, N 5.14.
553 (3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
554 dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-4,6-dioxotetrahydro-
555 5H-[1,3]dithiolo[4,5-c]pyrrole-5-carboxamide (3i). 27 mg (38%),
556 orange solid, mp 114−115 °C (dec.) (EtOAc), 58/42 ratio of
557 conformers. IR (KBr): ν̃ = 3432, 2923, 1790, 1716, 1635, 1261, 1096
558 cm−1. 1H NMR (CDCl3, 300 MHz): δ 8.59 (br s, 2H, NH2), 5.15 (d, J
559 = 8.5 Hz, 0.58H, CH conformer A), 5.05 (d, J = 8.9 Hz, 0.42H, CH
560 conformer B), 4.90 (d, J = 8.5 Hz, 0.58H, CH conformer A), 4.66 (d, J
561 = 8.9 Hz, 0.42H, CH conformer B), 3.64−3.51 (m, 1H, CH2 conformer
562 A/B), 3.31−3.16 (m, 1H, CH2 conformer A/B), 1.15 (t, J = 6.9 Hz,
563 1.26H, CH3 conformer B), 1.14 (t, J = 6.9 Hz, 1.74H, CH3 conformer
564 A). 13C NMR (CDCl3, 75 MHz): δ 201.3, 200.9, 184.8, 172.3, 171.5,
565 171.4, 151.1, 150.4, 133.6, 132.5, 125.0 (Cq conformer A/B), 60.7
566 (CH conformer A), 59.7 (CH conformer B), 52.5 (CH conformer A),
567 51.2 (CH conformer B), 48.8 (CH2 conformer A), 48.7 (CH2 conformer
568 B), 13.3 (CH3 conformer A), 13.2 (CH3 conformer B). MS (FAB
+): m/
569 z (%) 464 (M+ + 1, 20), 391 (100), 340 (55), 177 (82). HRMS
570 (LSIMS): m/z 463.8984; calcd for [C13H9N3O4S6 + H]
+, 463.8991.
571 Anal. Calcd for C13H9N3O4S6: C 33.68, H 1.96, N 9.06. Found: C
572 33.56, H 2.08, N 8.97.
573 (3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
574 dithiolo[3 ,4-b ] [1 ,4] thiaz in-5(6H ) -y l idene)-5- (4- ( (E ) -
575 phenyldiazenyl)phenyl)dihydro-4H-[1,3]dithiolo[4,5-c]pyrrole-
5764,6(5H)-dione (3j). 47 mg (51%), orange solid, mp 175−176 °C
577(dec.) (EtOAc/MeOH 95:5), 55/45 ratio of conformers. IR (KBr): ν̃
578= 3010, 2957, 1789, 1718, 1667, 1380, 1189 cm−1. 1H NMR (CDCl3,
579400 MHz): δ 8.05−7.99 (m, 2H, HAr), 7.94−7.91 (m, 2H, HAr), 7.55−
5807.50 (m, 5H, HAr), 5.32 (d, J = 8.6 Hz, 0.55H, CH conformer A), 5.22
581(d, J = 9.0 Hz, 0.45H, CH conformer B), 5.06 (d, J = 8.6 Hz, 0.55H, CH
582conformer A), 4.85 (d, J = 9.0 Hz, 0.45H, CH conformer B), 3.66−3.51
583(m, 1H, CH2 conformer A/B), 3.35−3.18 (m, 1H, CH2 conformer A/
584B), 1.16 (t, J = 7.1 Hz, 1.35H, CH3 conformer B), 1.15 (t, J = 7.1 Hz,
5851.65H, CH3 conformer A).
13C NMR (CDCl3, 100 MHz): δ 201.2,
586200.8, 184.8, 184.6, 171.7, 171.5, 165.9, 163.8, 152.4, 152.2, 152.1,
587150.2, 133.6, 132.7, 132.6, 132.4 (Cq conformer A/B), 131.5, 129.1,
588126.7, 123.6, 123.5, 123.0 (CHAr), 60.0 (CH conformer A), 58.6 (CH
589conformer B), 51.5 (CH conformer A), 50.5 (CH conformer B), 48.8
590(CH2 conformer A), 48.7 (CH2 conformer B), 13.3 (CH3 conformer A/
591B). MS (FAB+): m/z (%) 601 (M+ + 1, 10), 600 (M+, 10). HRMS
592(LSIMS): m/z 600.9616; calcd for [C24H16N4O3S6 + H]
+, 600.9625.
593Anal. Calcd for C24H16N4O3S6: C 47.98, H 2.68, N 9.33. Found: C
59448.11, H 2.73, N 9.22.
595General Procedure for the Catalytic Cycloaddition of 4-
596Benzylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3-oxo-5-thione
597(5) and Maleimides 2a−c,e−g. Maleimide 2a−c,e−g (1 equiv) and
598Sc(OTf)3 (19 mg, 0.039 mmol) were added under nitrogen to 5 (60
599mg, 0.16 mmol) dissolved in dry dichloromethane (10 mL), and the
600mixture was reﬂuxed for 2 h (for 2a,c), 3 h (for 2b,e,f), or 4 h (for 2g).
601Then the solvent was evaporated under reduced pressure, and the
602residue was puriﬁed by column chromatography [silica 230−400
603mesh, eluting with light petroleum to dichoromethane (or a
604dichloromethane/ethyl acetate 95:5 mixture for 6a,g)] to get 6a−
605c,e−g. Analytical samples were obtained by thin-layer chromatography
606(glass plates, silica 20 cm × 20 cm × 0.1 cm, eluting with
607dichloromethane or dichloromethane/ethyl acetate mixtures).
608(3aR,6aS)(Z/E)-2-(4-Benzyl-3-oxo-6-thioxo-3H,4H-[1,2]-
609dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)dihydro-4H-[1,3]-
610dithiolo[4,5-c]pyrrole-4,6(5H)-dione (6a). 50 mg (67%), orange
611solid, mp 142−144 °C (dec.) (DCM/EtOAc 95:5), 66/34 ratio of
612conformers. IR (KBr): ν̃ = 3435, 1790, 1715, 1648, 1264 cm−1. 1H
613NMR (CDCl3, 300 MHz): δ 9.22 (br s, 1H, NH), 7.33−7.19 (m, 3H,
614HAr), 7.06−7.04 (m, 2H, HAr), 5.18 (d, J = 8.5 Hz, 0.66H, CH
615conformer A), 5.08 (d, J = 9.0 Hz, 0.34H, CH conformer B), 4.94 (d, J =
6168.5 Hz, 0.66H, CH conformer A), 4.57 (d, J = 9.0 Hz, 0.34H, CH
617conformer B), 4.52 (d, J = 14.2 Hz, 0.66H, CH2 conformer A), 4.49 (d,
618J = 13.6 Hz, 0.34H, CH2 conformer B), 4.20−4.08 (m, 1H, CH2
619conformer A/B). 13C NMR (CDCl3, 75 MHz): δ 200.9, 200.4, 184.8,
620184.7, 173.2, 172.8, 172.6, 172.4, 165.0, 162.8, 151.9, 151.4 (Cq
621conformer A/B), 135.2, 135.1 (CHAr conformer A/B), 133.2, 133.1,
622132.9, 131.7, 131.6 (Cq conformer A/B), 129.6, 129.5, 128.5, 128.4
623(CHAr conformer A/B), 127.9, 127.5 (Cq conformer A/B), 61.0 (CH
624conformer A), 60.0 (CH conformer B), 57.4 (CH2), 52.7 (CH
625conformer A), 51.4 (CH conformer B). MS (FAB+): m/z (%) 483 (M+
626+ 1, 6), 391 (20), 274 (60). HRMS (LSIMS): m/z 482.9096; calcd for
627[C17H10N2O3S6 + H]
+, 482.9089. Anal. Calcd for C17H10N2O3S6: C
62842.31, H 2.09, N 5.80. Found: C 42.22, H 2.21, N 5.69.
629(3aR,6aS)(Z/E)-2-(4-Benzyl-3-oxo-6-thioxo-3H,4H-[1,2]-
630dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-5-methyldihydro-4H-
631[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (6b). 54 mg (70%),
632orange solid, mp 200−203 °C (dec.) (DCM). IR (KBr): ν̃ = 1706,
6331660, 1432, 1283 cm−1. 1H NMR (CDCl3, 300 MHz): δ 7.32−7.04
634(m, 5H, HAr), 5.15 (d, J = 8.6 Hz, 0.59H, CH conformer A), 5.07 (d, J
635= 9.0 Hz, 0.41H, CH conformer B), 4.92 (d, J = 8.6 Hz, 0.59H, CH
636conformer A), 4.67 (d, J = 9.0 Hz, 0.41H, CH conformer B), 4.56 (d, J =
63714.3 Hz, 0.59H, CH2 conformer A), 4.50 (d, J = 14.7 Hz, 0.41H, CH2
638conformer B), 4.17−4.12 (m, 1H, CH2 conformer A/B), 3.15 (s, 1.23H,
639CH3 conformer B), 3.06 (s, 1.77H, CH3 conformer A).
13C NMR
640(CDCl3, 75 MHz): δ 201.0, 200.6, 184.5, 184.3, 172.9, 172.5, 172.2,
641172.1, 171.1, 164.8, 162.4, 151.8, 150.9 (Cq conformer A/B), 135.1,
642135.2 (CHAr conformer A/B), 133.1, 132.9, 131.6 (Cq conformer A/
643B), 129.6, 129.5, 128.5, 128.4 (CHAr conformer A/B), 59.8 (CH
644conformer A), 58.7 (CH conformer B), 57.4 (CH2 conformer B), 57.3
645(CH2 conformer A), 51.4 (CH conformer A), 50.3 (CH conformer B),
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646 26.1 (CH3 conformer B), 25.9 (CH3 conformer A). MS (FAB
+): m/z
647 (%) 497 (M+ + 1, 10), 464 (15), 405 (60), 301 (100). HRMS
648 (LSIMS): m/z 495.9181; calcd for C18H12N2O3S6
+, 495.9172. Anal.
649 Calcd for C18H12N2O3S6: C 43.53, H 2.44, N 5.64. Found: C 43.64, H
650 2.35, N 5.52.
651 (3aR,6aS)(Z/E)-2-(4-Benzyl-3-oxo-6-thioxo-3H,4H-[1,2]-
652 dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-5-(tert-butyl)-
653 dihydro-4H-[1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (6c). 62
654 mg (74%), orange solid, mp 185−186 °C (dec.) (DCM), 55/45
655 ratio of conformers. IR (KBr): ν̃ = 1706, 1650, 1331, 1159 cm−1. 1H
656 NMR (CDCl3, 300 MHz): δ 7.31−7.04 (m, 5H, HAr), 5.02 (d, J = 8.8
657 Hz, 0.55H, conformer A), 4.89 (d, J = 9.1 Hz, 0.45H, conformer B),
658 4.79 (d, J = 8.8 Hz, 0.55H, conformer A), 4.58−4.49 (m, 1.45H, CH
659 conformer B and CH2 conformer A/B), 4.20−4.11 (m, 1H, CH2
660 conformer A/B), 1.64 (s, 4.05H, (CH3)3 conformer B), 1.58 (s, 4.95 H
661 (CH3)3 conformer A).
13C NMR (CDCl3, 75 MHz): δ 200.6, 200.2,
662 184.4, 184.1, 172.9, 172.5, 172.3, 172.4, 164.7, 162.4, 151.5, 151.0 (Cq
663 conformer A/B), 135.0, 134.8 (CHAr conformer A/B), 132.8, 132.7,
664 132.5, 131.3, 131.2 (Cq conformer A/B), 129.2, 129.0, 128.1, 127.9
665 (CHAr conformer A/B), 127.4, 127.1 (Cq conformer A/B), 60.5 (CH
666 conformer A), 60.4 (Cq conformer A/B), 59.9 (CH conformer B), 58.5
667 (CH2), 52.3 (CH conformer A), 51.0 (CH conformer B), 29.7 (3 ×
668 CH3 conformer B), 28.1 (3 × CH3 conformer A). MS (FAB
+): m/z (%)
669 539 (M+ + 1, 30), 447 (70), 391 (70), 349 (90). HRMS (LSIMS): m/
670 z 537.9635; calcd for C21H18N2O3S6
+, 537.9642. Anal. Calcd for




675 dithiolo[4,5-c]pyrrole-4,6(5H)-dione (6e). 59 mg (66%), orange
676 solid, mp 116−117 °C (dec.) (DCM), 62/38 ratio of conformers. IR
677 (KBr): ν̃ = 3024, 2924, 1709, 1649, 1387, 1276, 1064 cm−1. 1H NMR
678 (CDCl3, 300 MHz): δ 7.43−7.20 (m, 8H, HAr), 7.06−7.01 (m, 2H,
679 HAr), 5.11 (d, J = 8.6 Hz, 0.62H, CH conformer A), 5.02 (d, J = 9.0 Hz,
680 0.38H, CH conformer B), 4.91 (d, J = 8.6 Hz, 0.62H, CH conformer A),
681 4.77 (s, 0.76H, CH2 conformer B), 4.67 (s, 1.24H, CH2 conformer A),
682 4.64 (d, J = 9.0 Hz, 0.38H, CH conformer B), 4.59 (d, J = 14.3 Hz,
683 0.62H, CH2 conformer A), 4.52 (d, J = 14.2 Hz, 0.38H, CH2 conformer
684 B), 4.12 (d, J = 14.2 Hz, 0.38H, CH2 conformer B), 4.11 (d, J = 14.3 Hz,
685 0.62H, CH2 conformer A).
13C NMR (CDCl3, 75 MHz): δ 201.1,
686 200.6, 184.5, 184.4, 172.5, 172.1, 171.9, 171.8, 164.5, 162.4, 151.7,
687 150.9, 135.3, 135.1, 134.5, 134.4, 133.1, 132.9, 131.7, 131.6 (Cq
688 conformer A/B), 129.6, 129.5, 129.1, 128.9, 128.8, 128.5, 128.4 (CHAr
689 conformer A/B), 59.9 (CH conformer A), 58.8 (CH conformer B), 57.4
690 (CH2 conformer A/B), 51.4 (CH conformer A), 50.2 (CH conformer
691 B), 43.7 (CH2 conformer A/B). MS (FAB
+): m/z (%) 573 (M+ + 1,
692 50), 481 (100), 386 (85), 296 (69), 214 (71). HRMS (LSIMS): m/z
693 572.9564; calcd for [C24H16N2O3S6 + H]
+, 572.9558. Anal. Calcd for




698 [1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione (6f). 44 mg (51%),
699 orange solid, mp 210−211 °C (dec.) (DCM), 65/35 ratio of
700 conformers. IR (KBr): ν̃ = 3024, 1705, 1654, 1623, 1383, 1184
701 cm−1. 1H NMR (DMSO-d6, 400 MHz): δ 7.56−6.99 (m, 10H, HAr),
702 5.83 (d, J = 8.9 Hz, 0.65H, CH conformer A), 5.66 (d, J = 9.2 Hz,
703 0.35H, CH conformer B), 5.58 (d, J = 8.9 Hz, 0.65H, CH conformer A),
704 5.35 (d, J = 9.2 Hz, 0.35H, CH conformer B), 4.40 (d, J = 14.4 Hz,
705 0.65H, CH2 conformer A), 4.37 (d, J = 14.1 Hz, 0.35H, CH2 conformer
706 B) 4.19 (d, J = 14.1 Hz, 0.35H, CH2 conformer B), 4.12 (d, J = 14.4 Hz,
707 0.65H, CH2 conformer A).
13C NMR (DMSO-d6, 100 MHz): δ 200.6,
708 199.9, 184.9, 173.1, 172.8, 172.6, 168.4, 166.6, 152.0, 151.7, 135.5,
709 132.0, 131.7, 131.6, 131.5 (Cq conformer A/B), 129.4, 129.3, 129.1,
710 129.0, 128.9, 128.3, 128.2, 127.0, 126.9 (CHAr), 60.7 (CH conformer
711 A), 59.5 (CH conformer B), 56.6 (CH2 conformer A), 56.5 (CH2
712 conformer B), 51.8 (CH conformer A), 50.6 (CH conformer B). MS
713 (FAB+): m/z (%) 559 (M+ + 1, 15), 467 (62), 386 (50), 295 (40), 237
714 (100). HRMS (LSIMS): m/z 557.9322; calcd for C23H14N2O3S6
+,
715557.9329. Anal. Calcd for C23H14N2O3S6: C 49.44, H 2.53, N 5.01.




720mg (48%), orange solid, mp 155−156 °C (dec.) (DCM/EtOAc
72195:5), 55/45 ratio of conformers. IR (KBr): ν̃ = 3022, 1707, 1654,
7221380, 1182 cm−1. 1H NMR (CDCl3, 300 MHz): δ 7.87−7.77 (m, 2H,
723HAr), 7.37−7.05 (m, 7H, HAr), 5.31 (d, J = 8.4 Hz, 0.55H, CH
724conformer A), 5.19 (d, J = 8.9 Hz, 0.45H, CH conformer B), 5.08 (d, J =
7258.4 Hz, 0.55H, CH conformer A), 4.83 (d, J = 8.9 Hz, 0.45H, CH
726conformer B), 4.58 (d, J = 14.2 Hz, 0.55H, CH2 conformer A), 4.54 (d,
727J = 14.2 Hz, 0.45H, CH2 conformer B), 4.19 (d, J = 14.2 Hz, 0.45H, CH2
728conformer B), 4.15 (d, J = 14.2 Hz, 0.55H, CH2 conformer A).
13C
729NMR (CDCl3, 75 MHz): δ 201.3, 201.0, 184.4, 171.4, 171.1, 170.6,
730170.5, 151.7, 150.8 (Cq conformer A/B), 138.6, 138.5 (CHAr
731conformer A/B), 135.2, 135.0, 133.4, 131.6 (Cq conformer A/B),
732129.7, 129.6, 128.8, 128.5, 127.7, 127.6 (CHAr conformer A/B), 94.9,
73394.8 (Cq conformer A/B), 59.9 (CH conformer A), 58.6 (CH
734conformer B), 57.4 (CH2), 51.6 (CH conformer A), 50.4 (CH
735conformer B). MS (FAB+): m/z (%) 685 (M+ + 1, 10), 593 (30), 410
736(28), 340 (80), 177 (100). HRMS (LSIMS): m/z 684.8374; calcd for
737[C23H13IN2O3S6 + H]
+, 684.8368. Anal. Calcd for C23H13IN2O3S6: C
73840.35, H 1.91, N 4.09. Found: C 40.44, H 1.83, N, 3.98.
739General Procedure for the Catalytic Cycloaddition of 4-
740Ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3,5-dithione (7)
741and Maleimides 2b,f,g. Maleimide 2b,f,g (2 equiv) and Sc(OTf)3
742(37 mg, 0.075 mmol) were added under nitrogen to 7 (50 mg, 0.15
743mmol) dissolved in dry dichloromethane (10 mL), and the mixture
744was reﬂuxed for 1 h (for 2b,g) or 2 h (for 2c). Then the solvent was
745evaporated under reduced pressure, and the residue was puriﬁed by
746column chromatography [silica 230−400 mesh, eluting with light
747petroleum to dichloromethane/ethyl acetate mixtures (95:5 for 8b,g,
74890:10 for 8f)] to get 8b,f,g. Analytical samples were obtained by thin-
749layer chromatography (glass plates, silica 20 cm × 20 cm × 0.1 cm,
750eluting with dichloromethane/ethyl acetate mixtures).
751(2Z/E,2′E/Z,3aR,3a′R,6aS,6a′S)-2,2′-(4-Ethyl-2,6-dithioxothio-
752morpholine-3,5-diylidene)bis(5-methyldihydro-4H-[1,3]-
753dithiolo[4,5-c]pyrrole-4,6(5H)-dione) (8b). 54 mg (65%), light-
754brown solid, mp 144−145 °C (dec.) (DCM/EtOAc 95:5), 60/24/13/
7553 ratio of conformers. IR (KBr): ν̃ = 1708, 1650, 1420, 1365 cm−1. 1H
756NMR (DMSO-d6, 400 MHz): δ 5.66−5.51 (m, 2H, 2 × CH
757conformer A/B/C), 5.36−5.22 (m, 2H, 2 × CH conformer A/B/C),
7583.30−3.20 (m, 2H, CH2), 2.95 (s, 1.49H, 2 × CH3 conformer B), 2.94
759(s, 1.83H, CH3 conformer A), 2.90 (s, 1.83H, CH3 conformer A), 2.89
760(s, 0.85H, 2 × CH3 conformer C), 1.14−1.03 (m, CH3). 13C NMR
761(DMSO-d6, 100 MHz): δ 201.1, 199.8, 199.7, 198.4, 173.9, 173.8,
762173.6, 173.5, 173.4, 173.3, 173.1, 172.0, 171.9, 171.3, 170.8, 135.0,
763134.3, 134.0, 133.2 (Cq conformer A/B/C), 60.4, 60.3, 59.8, 59.6,
76451.0, 50.9, 50.4 (CH conformer A/B/C), 50.3 (CH2), 50.0 (CH
765conformer A/B/C), 25.6, 25.5, 25.4 (CH3 conformer A/B/C), 13.0,
76612.9 (CH3 conformer A/B/C). MS (FAB
+): m/z (%) 562 (M+ + 1,
76712), 392 (30), 281 (36), 167 (100). HRMS (LSIMS): m/z 561.9175;
768calcd for [C18H15N3O4S7 + H]
+, 561.9181. Anal. Calcd for C18H
76915N3O4S7: C 38.49, H 2.69, N 7.48. Found: C 38.36, H 2.77, N 7.40.
770(2Z/E,2′E/Z,3aR,3a′R,6aS,6a′S)-2,2′-(4-Ethyl-2,6-dithioxothio-
771morpholine-3,5-diylidene)bis(5-phenyldihydro-4H-[1,3]-
772dithiolo[4,5-c]pyrrole-4,6(5H)-dione) (8f). 68 mg (67%), light-
773brown solid, mp 104−105 °C (dec.) (DCM/EtOAc 90:10), 45/45/7/
7743 ratio of conformers. IR (KBr): ν̃ = 1717, 1633, 1378 cm−1. 1H NMR
775(DMSO-d6, 400 MHz): δ (for the main conformer) 7.52−7.33 (m,
77610H, HAr), 5.81 (d, J = 8.8 Hz, 1H, CH), 5.68 (d, J = 9.0 Hz, 1H, CH),
7775.54 (d, J = 8.8 Hz, 1H, CH), 4.45 (d, J = 9.0 Hz, 1H, CH), 3.35 (q, J
778= 7.0 Hz, 2H, CH2), 1.12 (t, J = 7.0 Hz, 3H, CH3).
13C NMR
779(DMSO-d6, 100 MHz): δ (for the main conformer) 201.0, 198.7,
780173.0, 172.9, 172.6, 172.5, 172.1, 171.0, 135.0, 133.6 (Cq), 131.6,
781131.5, 129.2, 129.1, 127.0, 126.9 (CHAr), 60.7, 60.1, 51.5, 50.7 (CH),
78250.5 (CH2), 13.0 (CH3). MS (FAB
+): m/z (%) 686 (M+ + 1, 40), 513
783(58). HRMS (LSIMS): m/z 685.9485; calcd for [C28H19N3O4S7 +
784H]+, 685.9494. Anal. Calcd for C28H19N3O4S7: C 49.03, H 2.79, N
7856.13. Found: C, 49.12, H 2.68, N 6.05.
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786 (2Z/E,2′E/Z,3aR,3a′R,6aS,6a′S)-2,2′-(4-Ethyl-2,6-dithioxothio-
787 morpholine-3,5-diylidene)bis(5-(4-iodophenyl)dihydro-4H-
788 [1,3]dithiolo[4,5-c]pyrrole-4,6(5H)-dione) (8g). 21 mg (15%),
789 light-brown solid, mp 184−185 °C (dec.) (DCM/EtOAc 95:5), 75/
790 12/11/2 ratio of conformers. IR (KBr): ν̃ = 1710, 1640, 1375 cm−1.
791
1H NMR (DMSO-d6, 400 MHz): δ (for the main conformer) 7.92−
792 7.85 (m, 2H, HAr), 7.70−7.65 (m, 2H, HAr), 7.21−7.17 (m, 2H, HAr),
793 7.10−7.07 (m, 2H, HAr), 5.78 (d, J = 8.7 Hz, 2H, 2 × CH), 5.47 (d, J =
794 8.7 Hz, 2H, 2 × CH), 3.32 (q, J = 7.2 Hz, 2H, CH2), 1.24 (t, J = 7.2
795 Hz, 3H, CH3).
13C NMR (DMSO-d6, 100 MHz): δ (for the main
796 conformer) 199.9, 172.7, 172.2, 172.0 (Cq), 137.8 (CHAr), 134.4,
797 131.1 (Cq), 129.0 (CHAr), 95.2 (Cq), 60.5 (CH), 51.5 (CH), 34.31
798 (CH2), 13.0 (CH3). MS (FAB
+): m/z (%) 938 (M+ + 1, 1). Anal.
799 Calcd for C28H17I2N3O4S7: C 35.87, H 1.83, N 4.48. Found: C 35.96,
800 H 1.75, N 4.36.
801 General Procedure for the Catalytic Cycloaddition of 4-
802 Ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3-oxo-5-thione 1
803 and Bismaleimides 9a−c. Bismaleimide 9a−c (1 equiv) and
804 Sc(OTf)3 (19 mg, 0.038 mmol or 37 mg, 0.075 mmol) were added
805 under nitrogen to 1 equiv (50 mg, 0.15 mmol, method A) or 2 equiv
806 (100 mg, 0.30 mmol, method B) of 1 dissolved in dry dichloro-
807 methane (10 mL), and the mixture was reﬂuxed for 1 h. Then the
808 solvent was evaporated under reduced pressure, and the residue was
809 puriﬁed by column chromatography (silica 230−400 mesh, eluting
810 with light petroleum/dichloromethane 60:40 to dichloromethane/
811 ethyl acetate 90:10) to get 10a−b and 11a−c. Analytical samples were
812 obtained by thin-layer chromatography (glass plates, silica 20 cm × 20




817 dithiolo[4,5-c]pyrrole-4,6(5H)-dione (10a). 59 mg (56%) by
818 method A or 26 mg (25%) by method B, orange solid, mp 285−
819 286 °C (dec.) (DCM/EtOAc 90:10), 53/47 ratio of conformers. IR
820 (KBr): ν̃ = 1788, 1712, 1666, 1639, 1536, 1376 cm−1. 1H NMR
821 (CDCl3, 400 MHz): δ 7.32−7.21 (m, 8H, HAr), 6.83 (s, 0.94H, CHvin
822 conformer B), 6.82 (s, 1.06H, CHvin conformer A), 5.24 (d, J = 8.4 Hz,
823 0.53H, CH conformer A), 5.12 (d, J = 9.2 Hz, 0.47H, CH conformer B),
824 4.98 (d, J = 8.4 Hz, 0.53H, CH conformer A), 4.74 (d, J = 9.2 Hz,
825 0.47H, CH conformer B), 4.04 (s, 0.94H, CH2 conformer B), 4.01 (s,
826 1.06H, CH2 conformer A), 3.63−3.49 (m, 1H, CH2 conformer A/B),
827 3.31−3.16 (m, 1H, CH2 conformer A/B), 1.13 (t, J = 7.2 Hz, 1.59H,
828 CH3 conformer A), 1.12 (t, J= 7.2 Hz, 1.41H, CH3 conformer B).
13C
829 NMR and DEPT (CDCl3, 100 MHz): δ 201.1, 200.7, 184.7, 184.5,
830 171.8, 171.7, 171.1, 169.5, 165.0, 162.9, 151.1, 150.2, 141.8, 141.7,
831 140.0 (Cq conformer A/B), 134.2 (CH conformer A/B), 133.5, 133.4,
832 132.4 (Cq conformer A/B), 129.8, 129.7, 129.6 (CH conformer A/B),
833 129.4, 126.3, 129.0, 128.9 (Cq conformer A/B), 126.2, 126.1 (CH
834 conformer A/B), 59.9, 58.6, 51.5, 50.4 (CH conformer A/B), 48.8,
835 48.6 (CH2 conformer A/B), 41.1, 41.0 (CH2 conformer A/B), 13.3,
836 13.2 (CH3 conformer A/B). MS (FAB
+): m/z (%) 684 (M+ + 2, 9),
837 487 (22), 391 (45). HRMS (LSIMS): m/z 682.9813; calcd for
838 [C29H19N3O5S6 + 2H]
+, 682.9805. Anal. Calcd for C29H19N3O5S6: C




843 pyrrole-4,6(5H)-dione (10b). 25 mg (27%) by method A or 24 mg
844 (26%) by method B, orange solid, mp >300 °C (dec.) (DCM/EtOAc
845 90:10), 55/45 ratio of conformers. IR (KBr): ν̃ = 1789, 1715, 1666,
846 1634, 1536, 1367 cm−1. 1H NMR (CDCl3, 200 MHz): δ 7.57−7.42
847 (m, 4H, HAr), 6.88 (s, 0.9H, CHvin conformer B), 6.86 (s, 1.1H, CHvin
848 conformer A), 5.29 (d, J = 8.6 Hz, 0.55H, CH conformer A), 5.18 (d, J
849 = 8.9 Hz, 0.45H, CH conformer B), 5.04 (d, J = 8.6 Hz, 0.55H, CH
850 conformer A), 4.79 (d, J = 8.9 Hz, 0.45H, CH conformer B), 3.70−3.47
851 (m, 1H, CH2 conformer A/B), 3.37−3.13 (m, 1H, CH2 conformer A/
852 B), 1.15 (t, J = 7.1 Hz, 3H, CH3 conformer A/B).
13C NMR and
853 DEPT (CDCl3, 50 MHz): δ 201.4, 176.5, 171.9, 169.0 (Cq conformer
854 A/B), 134.3 (CH conformer A/B), 132.5 (Cq conformer A/B), 126.9,
855 126.8, 126.7, 126.3 (CH conformer A/B), 59.9, 58.6, 51.5, 50.4 (CH
856 conformer A/B), 48.8, 48.7 (CH2 conformer A/B), 13.3 (CH3
857conformer A/B). MS (FAB+): m/z (%) 593 (M+ + 2, 1). Anal.







865c]pyrrole-4,6(5H)-dione (11a). 10 mg (13%) by method A or 86 mg
866(55%) by method B, orange solid, mp 179−180 °C (dec.) (DCM/
867EtOAc 90:10), 25/28/23/24 ratio of conformers. IR (KBr): ν̃ = 1788,
8681719, 1665, 1657, 1633, 1510, 1376 cm−1. 1H NMR (CDCl3, 400
869MHz): δ 7.31−7.20 (m, 8H, HAr), 5.25 (d, J = 8.6 Hz, 0.50H,
870conformer A), 5.24 (d, J = 8.6 Hz, 0.52H, conformer B), 5.14 (d, J = 9.0
871Hz, 0.48H, conformer C), 5.13 (d, J = 8.9 Hz, 0.50H, conformer D), 4.99
872(d, J = 8.6 Hz, 0.50H, conformer A), 4.98 (d, J = 8.6 Hz, 0.52H,
873conformer B), 4.74 (d, J = 9.0 Hz, 0.48H, conformer C), 4.73 (d, J = 8.9
874Hz, 0.50H, conformer D), 4.04 (d, J = 10.5 Hz, 1H, CH2), 4.01 (d, J =
87510.5 Hz, 1H, CH2), 3.64−3.49 (m, 2H), 3.32−3.17 (m, 2H), 1.14 (t, J
876= 7.0 Hz, 6H, CH3).
13C NMR (CDCl3, 100 MHz): δ 201.5, 201.1,
877200.1, 185.0, 184.8, 172.1, 172.0, 171.9, 171.4, 171.3, 171.2, 165.0,
878163.0, 151.3, 150.4, 141.8, 141.7, 141.6, 133.8, 133.7, 132.7 (Cq
879conformers A/B/C/D), 130.2, 130.1, 130.0 (CHAr), 129.4, 129.3,
880129.2 (Cq conformers A/B/C/D), 126.5, 126.4 (CHAr), 60.2, 58.9,
88151.8, 50.6 (CH conformers A/B/C/D), 49.0, 48.9 (CH2 conformers
882A/B/C/D), 41.3 (CH2), 13.6 (CH3 conformers A/B/C/D). MS
883(FAB+): m/z (%) 1006 (M+ + 2, 14), 880 (15), 599 (32). HRMS
884(LSIMS): m/z 1005.8487; calcd for [C37H24N4O6S12 + 2H]
+,
8851005.8501. Anal. Calcd for C37H24N4O6S12: C 44.20, H 2.41, N






892pyrrole-4,6(5H)-dione (11b). 24 mg (17%) by method A or 34 mg
893(24%) by method B, orange solid, mp 214−215 °C (dec.) (DCM/
894EtOAc 90:10), mixture of conformers. IR (KBr): ν̃ = 1788, 1720,
8951666, 1633, 1536, 1361 cm−1. 1H NMR (CDCl3, 400 MHz): δ 7.53−
8967.46 (m, 4H, HAr), 5.28−5.25 (m, 1.11H, mixture of conformers),
8975.18−5.14 (m, 0.89H, mixture of conformers), 5.04−5.00 (m, 1.11H,
898mixture of conformers), 4.79−4.75 (m, 0.89H, mixture of con-
899formers), 3.65−3.51 (m, 2H, CH2), 3.36−3.17 (m, 2H, CH2), 1.17−
9001.12 (m, 6H, CH3).
13C NMR and DEPT (CDCl3, 100 MHz): δ
901201.5, 201.4, 184.7, 171.5, 171.3, 171.2, 170.7, 170.6, 150.1, 146.5,
902134.3, 133.7, 132.5 (Cq), 126.9 and 126.8 (CHAr), 59.9, 58.6, 51.5,
90350.4 (CH, mixture of conformers), 48.8, 48.7 (CH2, mixture of
904conformers), 13.3 (CH3, mixture of conformers). MS (FAB
+): m/z
905(%) 915 (M+ + 1, 12), 391 (18), 338 (21). HRMS (LSIMS): m/z
906914.7964; calcd for [C30H18N4O6S12 + H]
+, 914.7953. Anal. Calcd for







914dithiolo[4,5-c]pyrrole-4,6(5H)-dione (11c). 31 mg (21%) by
915method B, orange solid, mp 145−146 °C (dec) (DCM/EtOAc
91690:10), mixture of conformers. IR (KBr): ν̃ = 1783, 1709, 1651, 1393
917cm−1. 1H NMR (CDCl3, 400 MHz): δ 5.31−4.71 (m, 4H), 3.79 (m,
91814H), 3.29−3.18 (m, 2H), 1.18−1.12 (m, 6H). 13C NMR (CDCl3,
919100 MHz): δ 200.9, 200.6, 184.5, 173.3, 173.2, 172.4, 163.8, 150.4,
920133.4, 132.6, 132.5, 130.9, 128.8, 125.0 (Cq, mixture of conformers),
92170.0, 66.7 (CH2, mixture of conformers), 59.8, 58.8, 51.6, 50.1 (CH,
922mixture of conformers), 48.8, 48.7, 39.4, 39.2 (CH2, mixture of
923conformers), 13.3, 13.2 (CH3, mixture of conformers). MS (FAB
+):
924m/z (%) 956 (M+ + 2, 1). Anal. Calcd for C30H26N4O8S12: C 37.72, H
9252.74, N 5.87. Found: C 37.85, H 2.84, N 5.74.
926(3aR,6aS)(Z/E)-2-(4-Ethyl-3-oxo-6-thioxo-3H,4H-[1,2]-
927dithiolo[3,4-b][1,4]thiazin-5(6H)-ylidene)-5-(4-(4-((3aR,6aS)(E/
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935 4,6(5H)-dione (12). Maleimide 10a (60 mg, 0.088 mmol) and
936 Sc(OTf)3 (9 mg, 0.018 mmol) were added under nitrogen to 4-
937 ethylbis[1,2]dithiolo[3,4-b:4′,3′-e][1,4]thiazin-3,5-dithione (7) (15
938 mg, 0.044 mmol) dissolved in dry dichloromethane (10 mL), and
939 the mixture was reﬂuxed for 6 hours. Then the solvent was evaporated
940 under reduced pressure, and the residue was puriﬁed by column
941 chromatography (silica 230−400 mesh, eluting with light petroleum to
942 dichoromethane/ethyl acetate 50:50) to get 12 (56 mg, 74% yield).
943 An analytical sample of 12 was obtained by thin-layer chromatography
944 (glass plates, silica 20 cm × 20 cm × 0.1 cm, eluting with
945 dichloromethane/ethyl acetate 50:50). Yellow solid, mp 238−239
946 °C (dec.) (DCM/EtOAc 50:50). IR (KBr): ν̃ = 1790, 1715, 1664,
947 1635, 1537, 1378 cm−1. 1H NMR (CD2Cl2, 400 MHz): δ 7.37−7.19
948 (m, 16H, HAr), 5.23−4.78 (m, 8H, 8 × CH), 4.11−4.06 (m, 4H, 2 ×
949 CH2), 3.61−3.49 (m, 3H), 3.31−3.18 (m, 3H), 1.16−1.12 (m, 9H,
950 CH3).
13C NMR (CD2Cl2, 100 MHz): δ 201.9, 201,4, 184.8, 172.2,
951 171.9, 171.6, 171.5, 163.5, 151.3, 150.5, 142.1, 142.0 (Cq), 135.4
952 (CHAr), 134.4, 133.8, 133.7, 132.7 (Cq), 130.0, 126.6, 125.2 (CHAr),
953 60.3, 59.1, 51.8, 50.7 (CH), 49.0, 48.9, 41.2 (CH2), 13.3, 13.2 (CH3).
954 MS (FAB+): m/z (%) 1702 (M+ + 1, 58), 1552 (70), 1389 (78), 1341
955 (100). HRMS (LSIMS): m/z 1701.7826; calcd for [C66H43N7O10S19 +
956 H]+, 1701.7838. Anal. Calcd for C66H43N7O10S19: C 46.54, H 2.54, N
957 5.76. Found: C 46.54, H 2.54, N 5.76.
958 Catalytic Cycloaddition of 4-Ethylbis[1,2]dithiolo[3,4-b:4′,3′-
959 e][1,4]thiazin-3-oxo-5-thione (1) and Trismaleimide 13. Trisma-
960 leimide 13 (60 mg, 0.15 mmol) and Sc(OTf)3 [19 mg, 0.038 mmol
961 (method A)/37 mg, 0.075 mmol (method B)/56 mg, 0.11 mmol
962 (method C)] were added under nitrogen to 1 [50 mg, 0.15 mmol
963 (method A)/100 mg, 0.30 mmol (method B)/150 mg, 0.45 mmol
964 (method C)] dissolved in dry dichloromethane (10 mL), and the
965 mixture was reﬂuxed for 4 h. Then the solvent was evaporated under
966 reduced pressure, and the residue was puriﬁed by column
967 chromatography (silica 230−400 mesh, eluting with light petroleum
968 to dichloromethane/ethyl acetate 50:50) to get monoadduct 14,
969 diadduct 15, or triadduct 16. Analytical samples were obtained by thin-
970 layer chromatography (glass plates, silica 20 cm × 20 cm × 0.1 cm,




975 (ethane-2,1-diyl))bis(1H-pyrrole-2,5-dione) (14). 46 mg (42%) by
976 method A or 15 mg (14%) by method B or 12 mg (11%) by method
977 C, orange solid, mp 255−256 °C (dec.) (DCM/EtOAc 50:50), 57/43
978 ratio of conformers. IR (KBr): ν̃ = 3099, 1782, 1711, 1404, 1332 cm−1.
979
1H NMR (CDCl3, 400 MHz): δ 6.65 (s, 4H), 5.33 (d, J = 8.5 Hz,
980 0.57H, CH adduct A), 5.22 (d, J = 9.0 Hz, 0.43H, CH adduct B), 5.03
981 (d, J = 8.5 Hz, 0.57H, CH adduct A), 4.84 (d, J = 9.0 Hz, 0.43H, CH
982 adduct B), 3.59−3.52 (m, 1H), 3.48 (t, J = 6.6 Hz, 4H), 3.41−3.34 (m,
983 2H), 3.26−3.12 (m, 1H), 2.67 (t, J = 6.6 Hz, 4H), 2.61−2.47 (m, 2H),
984 1.11−1.08 (m, 3H). 13C NMR (CDCl3, 100 MHz): δ 200.8, 200.3,
985 185.0, 184.9, 184.7, 173.3, 172.9, 171.0, 170.7, 166.8, 164.6, 151.5,
986 150.4, 134.3, 134.2, 133.3, 133.2, 132.7, 132.6, 125.1, 60.4, 59.4, 52.7,
987 51.7, 51.4, 50.6, 48.9, 48.8, 37.9, 35.8, 35.7, 13.5, 13.4. MS (FAB+): m/
988 z (%) 711 (M+ + 2, 2). Anal. Calcd for C26H23N5O7S6: C 43.99, H







996 dione (15). 15 mg (19%) by method A or 61 mg (38%) by method B
997 or 32 mg (20%) by method C, orange solid, mp 240−241 °C (dec.)
998 (DCM/EtOAc 50:50), mixture of conformers. IR (KBr): ν̃ = 1783,
9991706, 1655, 1532, 1404, 1342 cm−1. 1H NMR (CDCl3, 400 MHz): δ
10006.65 (s, 2H), 5.49−4.79 (m, 4H), 3.56−3.13 (m, 10H), 2.68−2.45 (m,
10016H), 1.12−1.08 (m, 6H). 13C NMR (CDCl3, 100 MHz): δ 200.5,
1002199.9, 184.8, 184.7, 184.5, 173.7, 173.4, 172.8, 172.7, 171.3, 171.2,
1003170.8, 170.7, 170.5, 166.6, 164.5, 164.4, 151.3, 150.5, 150.2, 135.0,
1004133.9, 133.0, 132.7, 132.4, 132.3, 124.8, 60.3, 60.2, 59.5, 59.2, 52.0,
100551.2, 48.6, 37.7, 35.6, 35.5, 13.2, 13.1, 13.0. MS (FAB+): m/z (%) 1033
1006(M+ + 1, 49), 923 (25), 586 (38), 445 (18). HRMS (LSIMS): m/z
10071032.8699; calcd for [C34H28N6O8S12 + H]
+, 1032.8690. Anal. Calcd








1016(16). 7 mg (10%) by method A or 28 mg (20%) by method B or 90
1017mg (43%) by method C, orange solid, mp 197−198 °C (dec.) (DCM/
1018EtOAc 50:50), mixture of conformers. IR (KBr): ν̃ = 1781, 1710,
10191670, 1540, 1404, 1340 cm−1. 1H NMR (CDCl3, 400 MHz): δ 5.73−
10204.72 (m, 6H), 3.67−3.07 (m, 12H), 3.07−2.16 (m, 6H), 1.16−1.05
1021(m, 9H). 13C NMR (CDCl3, 100 MHz): δ 199.2, 185.1, 174.3, 164.4,
1022151.3, 133.4, 132.4, 60.7, 59.9, 52.3, 51.8, 51.6, 50.8, 49.0, 37.3, 13.3,
102313.2. MS (FAB+): m/z (%) 1356 (M+ + 1, 24), 1005 (27), 923 (41),
1024682 (34), 433 (22). HRMS (LSIMS): m/z 1355.7396; calcd for
1025[C42H33N7O9S18 + H]
+, 1355.7385. Anal. Calcd for C42H33N7O9S18: C
102637.18, H 2.45, N 7.23. Found: C 37.07, H 2.55, N 7.16.
1027Calculations. DFT calculations were performed with the hybrid
1028method known as B3LYP, in which the Becke three-parameter
1029exchange functional24 and the Lee−Yang−Parr correlation func-
1030tional25 are used, as implemented in the Gaussian 03 (revision C.02)
1031program suite.26 Geometry optimizations and the nitrogen inversion
1032barrier for the simpliﬁed model 3 and geometry optimizations for
1033compounds 3a, 3b, and 3f were calculated using the 6-31G(d) basis
1034for all the atoms, whereas for the complex 3f[Hg]2+·MeCN the
1035eﬀective core potentials (ECPs) of Hay and Wadt with a double-ζ
1036valence basis set (LANL2DZ)27 were used to describe Hg and the 6-
103731G(d) basis set was used for the rest of the atoms. Energy values for
1038structures related to model 3 and compounds 3a and 3b were
1039calculated by punctual calculations on the obtained geometries using
1040the same functional and the 6-311+G(2d,p) basis set for all atoms. The
1041transition state of the simpliﬁed model for 3 was conﬁrmed by a




1046Copies of 1H and 13C NMR spectra of the products and
1047coordinates of all stationary points for the calculated structures.
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